secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001294133-26-000014
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q1 revenue up 3.4% to $85.1M; net loss widens to $8.3M
-------------------------------------------------------------

- GAAP net loss of $8.3M vs $6.2M loss in Q1 2025; adjusted net loss $4.0M vs $2.9M.
- Adjusted EBITDA turned negative at -$1.4M vs +$0.04M a year ago on R&D investments.
- Cash and securities $111.5M, no debt; $30M share repurchase authorized, $1.9M executed.
- Introduced Aurora CPAP masks in U.S. and launched Rove 6 POC in Brazil.
- Appointed Jason Richardson as CFO and Dominic Hulton as CMO; reiterated full-year 2026 revenue guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000014/0001294133-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000129413326000014/ingn-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001294133-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer